Aminocaproic acid interactions
Aminocaproic acid (Amicar), an antifibrinolytic has 5 documented interactions across the FDA labels and fact sheets we index: 4 major, 0 moderate, 1 minor, and 0 where a label reports no significant interaction. Each entry below quotes the sentence behind it. This drug page is a starting point, not a verdict for your situation.
Interactions from the label
Major interactions (4)
Aminocaproic acid must not be used in the presence of DIC without concomitant heparin. (Aminocaproic acid label, Contraindications)
Aminocaproic acid must not be used in the presence of DIC without concomitant heparin. (Aminocaproic acid label, Contraindications)
- ProtamineMajor
• Protamine paracoagulation test is positive in DIC; a precipitate forms when protamine sulfate is dropped into citrated plasma. (Aminocaproic acid label, Contraindications)
Avoid concomitant use of tretinoin capsules and anti-fibrinolytic agents, such as tranexamic acid, aminocaproic acid or aprotinin [see Drug Interactions ( 7.4 )] . (Tretinoin label, Warnings and precautions)
Minor mentions (1)
There is no experience with antifibrinolytic agents (tranexamic acid, aminocaproic acid) in individuals receiving apixaban. (Apixaban label, Warnings and precautions)
Check Aminocaproic acid against everything you take. Add your full list; every pair is checked at once.
Open in the checkerNot medical advice. Severity reflects the label's wording, not your circumstances. A "major" flag can be routine under supervision and a "minor" one can matter at high doses. Ask a pharmacist.